Substituted amides

a technology of substituting amides and amides, applied in the field of substituting amides, can solve the problems of overeating, psychosis, hypothermia, memory loss, and sedation

Inactive Publication Date: 2005-10-20
MERCK SHARP & DOHME CORP
View PDF24 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0018] The present invention is also concerned with treatment of these conditions, and the use of compounds of the present invention for manufacture of a medicament useful in treating t

Problems solved by technology

Excessive exposure to Δ9-THC can lead to overeating

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Substituted amides
  • Substituted amides
  • Substituted amides

Examples

Experimental program
Comparison scheme
Effect test

reference example 1

[1451]

N-[2,3-Bis(4-chlorophenyl)-1-methylpropyl]-amine hydrochloride

[1452] The preparation of the two diastereomers (alpha and beta) of N-[2,3-bis(4-chlorophenyl)-1-methylpropyl]-amine hydrochloride salt has been disclosed (Schultz, E. M, et al. J. Med Chem. 1967,10, 717). Diastereomer α: LC-MS: calculated for C16H17Cl2N 293, observed m / e 294 (M+H)+ (Rt 2.5 min). Diastereomer β: LC-MS: calculated for C16H17Cl2N 293, observed m / e 294 (M+H)+ (Rt 2.2 min).

[1453] The amines of Reference Examples 2-9 were prepared by the same procedures described in Reference Example 1:

reference example 2

[1454]

2-Amino-3 4-diphenylbutane hydrochloride salt

[1455] Diastereomer α:

[1456] LC-MS: calculated for C16H19N 225, observed m / e 226 (M+H)+ (2.0 min).

[1457] Diastereomer β:

[1458] LC-MS: calculated for C16H19N 225, observed m / e 226 (M+H)+ (1.9 min).

reference example 3

[1459]

3-Amino-1,2-diphenylpentane hydrochloride salt

[1460] Diastereomer α:

[1461] LC-MS: calculated for C17H21N 239, observed m / e 240 (M+H)+ (2.1 min).

[1462] Diastereomer β:

[1463] LC-MS: calculated for C17H21N 239, observed m / e 240 (M+H)+ (2.0 min).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Massaaaaaaaaaa
Dimensionless propertyaaaaaaaaaa
Volumeaaaaaaaaaa
Login to view more

Abstract

Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] Not applicable. BACKGROUND OF THE INVENTION [0002] Marijuana (Cannabis sativa L.) and its derivatives have been used for centuries for medicinal and recreational purposes. A major active ingredient in marijuana and hashish has been determined to be Δ9-tetrahydrocannabinol (Δ9-THC). Detailed research has revealed that the biological action of Δ9-THC and other members of the cannabinoid family occurs through two G-protein coupled receptors termed CB1 and CB2. The CB1 receptor is primarily found in the central and peripheral nervous systems and to a lesser extent in several peripheral organs. The CB2 receptor is found primarily in lymphoid tissues and cells. Three endogenous ligands for the cannabinoid receptors derived from arachidonic acid have been identified (anandamide, 2-arachidonoyl glycerol, and 2-arachidonyl glycerol ether). Each is an agonist with activities similar to Δ9-THC, including sedation, hypothermia, intestinal immobilit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/165A61K31/27A61K31/40A61K31/4015A61K31/403A61K31/405A61K31/415A61K31/4192A61K31/4196A61K31/42A61K31/423A61K31/426A61K31/428A61K31/437A61K31/44A61K31/4402A61K31/4409A61K31/4436A61K31/445A61K31/4453A61K31/4545A61K31/4709A61K31/496A61K31/50A61K31/501A61K31/505A61K31/5377A61K31/553A61P1/04A61P1/10A61P1/16A61P3/04A61P3/06A61P3/10A61P5/24A61P9/04A61P9/06A61P9/10A61P9/12A61P9/14A61P11/06A61P13/12A61P15/00A61P15/10A61P17/00A61P19/02A61P19/06A61P25/00A61P25/06A61P25/08A61P25/16A61P25/18C07C233/12C07C233/13C07C235/06C07C235/18C07C235/20C07C235/34C07C235/74C07C235/78C07C237/06C07C255/55C07C255/60C07C271/14C07C271/22C07C275/30C07C311/03C07C323/41C07D207/27C07D209/08C07D209/34C07D209/52C07D209/94C07D211/34C07D213/36C07D213/40C07D213/56C07D213/61C07D213/64C07D213/65C07D213/68C07D213/89C07D215/06C07D231/12C07D233/36C07D233/70C07D233/80C07D237/14C07D237/28C07D237/32C07D239/34C07D249/04C07D249/08C07D249/12C07D249/18C07D261/08C07D261/20C07D263/58C07D267/14C07D277/20C07D277/30C07D277/36C07D277/64C07D277/74C07D295/12C07D295/13C07D295/14C07D295/15C07D401/12C07D409/12C07D413/12C07D471/04C07D513/04C07D521/00
CPCC07C233/13C07C235/06C07C235/20C07C235/34C07C235/74C07C235/78C07C237/06C07C255/55C07C255/60C07C271/14C07C271/22C07C275/30C07C311/03C07D209/34C07D209/94C07D211/34C07D213/64C07D213/65C07D213/68C07D215/06C07D231/12C07D233/56C07D233/70C07D237/28C07D237/32C07D239/34C07D249/04C07D249/08C07D249/12C07D263/58C07D267/14C07D277/30C07D277/36C07D295/13C07D295/15C07D513/04C07C2601/02C07C2601/04C07C2601/08C07C2601/14C07C2602/08A61P1/04A61P1/10A61P1/16A61P11/06A61P13/12A61P15/00A61P15/08A61P15/10A61P17/00A61P19/02A61P19/06A61P25/00A61P25/06A61P25/08A61P25/16A61P25/18A61P25/22A61P25/24A61P25/28A61P25/30A61P25/32A61P25/34A61P25/36A61P29/00A61P3/04A61P35/00A61P35/02A61P3/06A61P43/00A61P5/24A61P9/00A61P9/04A61P9/06A61P9/10A61P9/12A61P9/14A61P3/10
Inventor HAGMANN, WILLIAMLIN, LINUSSHAH, SHRENIKGUTHIKONDA, RAVINDRAQI, HONGBOCHANG, LINDALIU, PINGARMSTRONG, HELENJEWELL, JAMESLANZA, THOMAS
Owner MERCK SHARP & DOHME CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap